Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB076233

Syndecan-1/CD138 Antibody (004), FITC, Novus Biologicals™
SDP

Catalog No. NB076233 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB076233 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB076233 Supplier Novus Biologicals Supplier No. NBP290664F
Add to Cart
Add to Cart

Description

Rabbit Monoclonal Antibody

Syndecan-1/CD138 Monoclonal specifically detects Syndecan-1/CD138 in Mouse samples. It is validated for ELISA.

Specifications

Antigen Syndecan-1/CD138
Applications ELISA
Classification Monoclonal
Clone 4
Conjugate FITC
Formulation PBS
Gene Alias CD138, CD138 antigen, SDC, SYND1heparan sulfate proteoglycan fibroblast growth factor receptor, syndecan, syndecan 1, syndecan proteoglycan 1, syndecan-1
Host Species Rabbit
Immunogen This antibody was obtained from a rabbit immunized with purified, recombinant Mouse Syndecan-1/CD138 (NP_035649.1; Met1-Glu252).
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline B Cell Development and Differentiation Markers
Primary or Secondary Primary
Gene ID (Entrez) 6382
Test Specificity Has cross-reactivity in ELISA with: Rat SDC1 No cross-reactivity in ELISA with: Mouse SDC4
Target Species Mouse
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.